Contact A Lawyer
Near You

Contact us today for a complimentary consultation with a qualified attorney near you.

Fen phen and Primary Pulmonary Hypertension

Fen Phen and Primary Pulmonary Hypertension studies conducted in 1996 discovered that people taking the popular diet drug Fen Phen (marketed as Redux and Pondimin) were significantly more likely to develop the deadly condition known as Primary Pulmonary Hypertension (PPH). After these studies were publicized, seventy five more cases of Fen Phen and Primary Pulmonary Hypertension were reported to the FDA by patients injured by this defective weight loss drug.

After this Fen Phen and Primary Pulmonary Hypertension information was made public, the FDA ordered the drug's manufacturer, American Home Products, to recall Fen Phen. Before the recall, an estimated six to seven million Americans took this drug. American Home Products accumulated over $200 million dollars in revenue from sales of Fen Phen before pulling it from the shelves.

Studies of Fen Phen and Primary Pulmonary Hypertension have found that patients who took this medication anywhere from a month to a few years were in danger of developing serious cardiovascular side effects. Primary Pulmonary Hypertension claims the lives of over 100 Americans every year. PPH is a progressive and rare lung disorder for which there is no known cure.

The use of Fen Phen and Primary Pulmonary Hypertension side effects may or may not result in outward signs and symptoms of a problem. If a person does develop outward symptoms of PPH they may experience any of the following: chest pains, shortness of breath (particularly with physical exertion), peripheral swelling, fainting spells, excessive fatigue, a racing pulse, and heart palpitations.

The diagnosis of Fen Phen and Primary Pulmonary Hypertension can be difficult to make. A proper diagnosis of Primary Pulmonary Hypertension requires meticulous consideration of a patient's personal and family medical history and their use of illegal and prescription drugs. An echocardiogram and other medical tests can be performed by a medical professional to determine if a person who has taken Fen Phen has developed PPH or any other cardiovascular abnormalities.

When a person does suffer the damages caused by Fen Phen and Primary Pulmonary Hypertension, there are some medical treatments that can be employed to manage a patient's condition. Drug therapy, surgery, medical devices, and other methods may be used to manage a patient's PPH. Pregnancy is highly contraindicated in people who suffer from PPH and maternal death following delivery is not uncommon. People who are diagnosed with PPH have an average life expectancy of three years.

Fen Phen and Primary Pulmonary Hypertension injuries provide viable legal grounds for an injured victim to seek compensation from the manufacturers of this defective product. Thousands of people have suffered from Fen Phen and Primary Pulmonary Hypertension. If you would like to learn more about Fen Phen and Primary Pulmonary Hypertension, please contact us to speak to a qualified and experienced attorney in your area.

Contact a Fenphen Recall Lawyer

More Fenphen Resources

Pulmonary Hypertension Resource - News, Information and Resources regarding Primary Pulmonary Hypertension and other forms of Severe Pulmonary Hypertension.

Pulmonary Hypertension Association - Features association background, disease and treatment information, news, research, and message boards.